Micrhogam Ultra-filtered Plus Coupons & Savings Card – Discount Prices from $1714.30

MicRhoGAM Ultra-Filtered Plus is a medication derived from human plasma, used to prevent Rh-negative individuals from developing antibodies against Rh-positive blood cells. While it is generally safe and effective, there are important safety considerations to be aware of:

Hypersensitivity Reactions: Some individuals may experience severe allergic reactions to this medication, even if they have previously tolerated similar treatments. Symptoms can include hives, chest tightness, wheezing, low blood pressure, and anaphylaxis. Therefore, it is crucial that administration occurs in a setting equipped to manage such reactions, with trained personnel and appropriate medications readily available.

Transmission of Infectious Agents: Since this product is made from human blood, there is a potential, albeit low, risk of transmitting infectious agents, such as viruses or, theoretically, the Creutzfeldt-Jakob disease agent. Rigorous screening and manufacturing processes are in place to minimize this risk, but it cannot be entirely eliminated.

Hemolysis Risk: In rare cases, administration to individuals who are Rh-positive or have received Rh-positive red blood cells may lead to hemolytic reactions. Symptoms can include fever, back pain, nausea, vomiting, changes in blood pressure, and the presence of hemoglobin in the urine. Patients treated for Rh-incompatible transfusion should be closely monitored for signs of hemolysis.

Interference with Laboratory Tests: After receiving this medication, there may be a temporary increase in certain antibodies in the blood, which can lead to positive results in some serological tests. This could potentially cause misleading interpretations of laboratory results.

Contraindications: This medication should not be used in Rh-positive individuals or in patients with a known history of severe allergic reactions to human immune globulin products.

It's essential to discuss these risks with your healthcare provider to determine if MicRhoGAM Ultra-Filtered Plus is appropriate for your situation.

MicRhoGAM Ultra-Filtered Plus is generally well-tolerated, but like all medications, it can cause side effects. The most common side effect is soreness at the injection site. Less commonly, individuals may experience mild reactions such as fever, chills, headache, dizziness, nausea, vomiting, diarrhea, joint or muscle pain, and skin rash or itching. In rare instances, more serious side effects can occur, including:

• Back pain
• Shaking chills
• Fever
• Dark urine
• Decreased urination
• Sudden weight gain
• Swelling of the hands or feet
• Shortness of breath
• Unusual bleeding or bruising
• Unusual tiredness or weakness
• Pale skin
• Nausea or vomiting
• Loss of appetite
• Increased thirst
• Increased blood pressure
• Bloody urine Additionally, serious allergic reactions, including anaphylaxis, may occur. Symptoms of anaphylaxis include itching, rash, hives, chest pain, dizziness, trouble breathing, or swelling of the hands, face, or mouth. Another rare but serious condition associated with this medication is intravascular hemolysis (IVH), which involves the destruction of red blood cells within the blood vessels. Symptoms of IVH include back pain, shaking chills, fever, dark urine, decreased urination, sudden weight gain, swelling of the hands or feet, and shortness of breath. If you experience any of these serious side effects, seek medical attention immediately. Always inform your healthcare provider about any side effects you encounter while using MicRhoGAM Ultra-Filtered Plus.

MicRhoGAM Ultra-Filtered Plus is a medication used to prevent Rh-negative individuals from developing antibodies against Rh-positive blood cells. It's important to be aware of potential interactions with other substances:

Vaccines: This medication can interfere with the effectiveness of live vaccines, such as those for measles, mumps, rubella, and varicella. To ensure optimal vaccine efficacy, it's recommended to delay live vaccinations until at least 12 weeks after the final dose of MicRhoGAM. If a live vaccine is administered within 14 days before or after receiving MicRhoGAM, the vaccine's effectiveness may be reduced.

Medications: While specific drug interactions with MicRhoGAM are not extensively documented, it's essential to inform your healthcare provider about all medications, supplements, and herbal products you're currently using. This ensures that any potential interactions are identified and managed appropriately.

Laboratory Tests: MicRhoGAM may affect certain laboratory tests, leading to false results. For instance, it can cause false readings in some blood glucose tests. Always inform laboratory personnel and your healthcare provider that you're receiving MicRhoGAM to ensure accurate test interpretations.

Before starting MicRhoGAM, discuss your full medical history and current treatments with your healthcare provider to ensure safe and effective use of the medication.